55 / 100
AltIndex AI Score
Hold
AI Score · 12-mo trend
Flat over 3 months
FundamentalsBullish
TechnicalsNeutral
Alternative dataNeutral
SentimentNeutral
Price$0.68
Year Range$0.5 – $1.27
Market Cap$35M
IndustryDigital health

What Is OneMedNet’s AI Stock Analysis?

OneMedNet’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks OneMedNet’s momentum in near-real time.

OneMedNet (ONMD) has an AltIndex AI Score of 55/100, currently a Hold signal. The AI Score distills OneMedNet's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.

OneMedNet’s Full AI Analysis

OneMedNet is a technology company specializing in data management and analytics solutions for the healthcare sector. The company aims to provide robust solutions that facilitate better data sharing, storage, and interoperability among healthcare entities. Since its inception, OneMedNet has garnered interest for its innovative approach to solving data challenges in the healthcare industry.

Fundamental Analysis

OneMedNet's financial performance has shown both promising signs and areas of concern. The revenue for the last quarter was $290,000. This marks an impressive increase of 204.17% compared to the previous quarter, suggesting rapid growth. Moreover, compared to the same quarter last year, revenue increased by 88.39%, signaling a positive year-over-year growth trend.

Premium

Keep reading AltIndex’s full AI analysis of OneMedNet — the fundamental, technical and alternative-data breakdown and the recommendation.

Sign up to read the full analysis

What’s Driving ONMD’s AI Score?

Fundamentals

Revenue for the last quarter was $290,000. This is an increase of 204.17% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 88.39%, suggesting positive year-over-year growth. Net income for the last quarter was $-2.2M. This is an increase of -11.46% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 172.84%, which may be a cause for concern. Ebitda for the last quarter was $-2.3M. This is an increase of -7.03% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 174.42%, which may be a cause for concern.

See OneMedNet’s earnings and insider transactions.

Technicals

Today's stock price is $0.68. This represents a decrease of 4.23% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 21.84%, which could be a cause for long-term concern. The trend is bullish. The current SMA10 is $0.59, which is higher than the previous SMA10 of $0.58. This indicates a potential upward trend in price movement. The RSI is 61.3, indicating a neutral condition.

See the full technical analysis and price prediction.

Alternative data

OneMedNet has an estimate of 1,000 visitors to their webpage, with no meaningful increase or decrese in the last couple of months.

Explore OneMedNet’s job postings, web traffic and app downloads.

Sentiment & social

OneMedNet has 300 followers on their Twitter page, with no meaningful increase or decrese in the last couple of months.

Track OneMedNet’s market sentiment.

Frequently Asked Questions: OneMedNet AI Stock Analysis

OneMedNet's AltIndex AI Score is 55/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.

AltIndex's AI Score model rates OneMedNet a Hold (55/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.

The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.

AltIndex generates a complete written AI analysis of OneMedNet — company overview, fundamentals, technicals and alternative data, with a recommendation. See the ONMD AI Score or sign up to read the full thesis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.